Live News Categoriesequity

Satellos Bioscience Inc. (MSCL.TO) News

Track canonical SquawkNews coverage tagged to MSCL.TO, Satellos Bioscience Inc.. This hub brings together deduplicated headlines about toronto, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol MSCL.TO Asset equity Sector Markets 90 days 1 Last 12.17 Updated Sep 24, 2026, 11:05 AM UTC Open live news feed

L Satellos wins FDA IND clearance for forazapadin in FSHD Satellos won FDA clearance for its IND to test forazapadin in facioscapulohumeral muscular dystrophy. FSHD Canada Foundation committed up to USD 5 million in non-dilutive milestone funding for the program. Phase 2 proof- REGULATION | Sep 24, 2026, 11:05 AM UTC